Stanislav Drápela (Stanislav Drapela)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Postmenopausal Women

Transcription Factor

Breast Cancer Cells

Editorial Comment

Top Venues

Molecular oncology

Clinical & experimental metastasis

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Islam E Elkholi, Amélie Robert, Camille Malouf, Hellen Kuasne, Stanislav Drápela, Graham MacLeod, Steven Hébert, Alain Pacis, Virginie Calderon, Claudia L Kleinman, Ana P Gomes, Julio A Aguirre-Ghiso, Morag Park, Stephane Angers, Jean-François Côté
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation. bioRxiv : the preprint server for biology (2024)
Stanislav Drápela, Didem Ilter, Ana P Gomes
Metabolic reprogramming: a bridge between aging and tumorigenesis. Molecular oncology 16 (18) (2022)
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek, Filip Trčka, Jan Verner, Stanislav Drápela, Radek Fedr, Tereza Suchánková, Barbora Pavlatovská, Eva Ondroušková, Irena Kubelková, Danica Zapletalová, Štěpán Tuček, Peter Múdry, Dagmar Adámková Krákorová, Lucia Knopfová, Jan Šmarda, Karel Souček, Lubor Borsig, Petr Beneš
Transcription factor c-Myb: novel prognostic factor in osteosarcoma. Clinical & experimental metastasis 39 (2) (2022)
Stanislav Drápela, Prashant Khirsariya, Thomas A Kirkland, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Cerveny, Aleš Hampl, Martin Puhr, William R Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe. Molecular oncology 14 (10) (2020)